Table 5.
Comparison of present series to prospective preoperative chemoradiotherapy trials in gastric cancer
| Series | Patients (n) | R0 resection (%)* | pCR rate (%)* | Overall survival (%)** |
|---|---|---|---|---|
| M.D. Anderson (Lowy et al.) |
24 |
95 |
11 |
N/A |
| Multi-institutional (Ajani et al.) |
33 |
82 |
36 |
54 (2) |
| M.D. Anderson(Ajani et al.) |
41 |
80 |
20 |
N/A |
| RTOG 9904 (Ajani et al.) |
43 |
75 |
31 |
72 (1) |
| Current series (Pepek et al.) | 48 | 86 | 19 | 40 (3) |
* Percentages are based on number of patients who underwent surgery after preoperative chemoradiotherapy.
** Numbers in parentheses are actuarial data in years.